Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Current Leases (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Current Leases for 2 consecutive years, with $3.4 million as the latest value for Q3 2023.

  • Quarterly Current Leases fell 26.09% to $3.4 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Sep 2023, down 26.09% year-over-year, with the annual reading at $4.0 million for FY2022, N/A changed from the prior year.
  • Current Leases for Q3 2023 was $3.4 million at LENZ Therapeutics, up from $2.9 million in the prior quarter.
  • The five-year high for Current Leases was $5.6 million in Q1 2022, with the low at $2.9 million in Q2 2023.